BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33615670)

  • 1. Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET.
    Raygada M; Raffeld M; Bernstein A; Miettinen M; Glod J; Hughes MS; Reilly K; Widemann B; Del Rivero J
    Am J Med Genet A; 2021 Apr; 185(4):1282-1287. PubMed ID: 33615670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Adrenocortical Carcinoma in Association With Lynch Syndrome.
    Challis BG; Kandasamy N; Powlson AS; Koulouri O; Annamalai AK; Happerfield L; Marker AJ; Arends MJ; Nik-Zainal S; Gurnell M
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2269-72. PubMed ID: 27144940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic, retroperitoneal adrenocortical carcinoma in the setting of Lynch syndrome.
    Wright JP; Montgomery KW; Tierney J; Gilbert J; Solórzano CC; Idrees K
    Fam Cancer; 2018 Jul; 17(3):381-385. PubMed ID: 28940135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
    Peppa M; Boutati E; Kamakari S; Pikounis V; Peros G; Panayiotides IG; Economopoulos T; Raptis SA; Hadjidakis D
    Eur J Endocrinol; 2008 Dec; 159(6):767-71. PubMed ID: 18805915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
    Weng Y; Xue SN; Zhang SL; Cheng H; Yan L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):134-137. PubMed ID: 29397600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal Hyperneury and Multiple Sclerotic Fibromas in Multiple Endocrine Neoplasia Type 2A Syndrome.
    Alegría-Landa V; Jo-Velasco M; Robledo M; Requena L
    JAMA Dermatol; 2017 Dec; 153(12):1298-1301. PubMed ID: 29049491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2.
    Verrienti A; Carbone A; Bellitti P; Fabiano MC; De Rose RF; Maranghi M; Lucia P; Durante C; Rosignolo F; Pecce V; Sponziello M; Puppin C; Costante G; Bruno R
    Endocr Pract; 2015 Nov; 21(11):1248-54. PubMed ID: 26247112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.
    Dvorakova S; Vaclavikova E; Ryska A; Cap J; Vlcek P; Duskova J; Kodetova D; Holub V; Novak Z; Bendlova B
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical carcinoma is a lynch syndrome-associated cancer.
    Raymond VM; Everett JN; Furtado LV; Gustafson SL; Jungbluth CR; Gruber SB; Hammer GD; Stoffel EM; Greenson JK; Giordano TJ; Else T
    J Clin Oncol; 2013 Aug; 31(24):3012-8. PubMed ID: 23752102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
    Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma].
    Wohllk N; Becker P; Youlton R; Cote GJ; Gagel RF
    Rev Med Chil; 2001 Jul; 129(7):713-8. PubMed ID: 11552438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
    Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
    Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family of multiple endocrine neoplasia type 2A (MEN 2A) with Cys630Tyr RET germline mutation: report of a case.
    Yonekawa H; Sugitani I; Fujimoto Y; Arai M; Yamamoto N
    Endocr J; 2007 Aug; 54(4):531-5. PubMed ID: 17527003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A (MEN2A).
    Takiguchi-Shirahama S; Koyama K; Miyauchi A; Wakasugi T; Oishi S; Takami H; Hikiji K; Nakamura Y
    Hum Genet; 1995 Feb; 95(2):187-90. PubMed ID: 7860065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.